Dr. Yong Tsai, M.D.
What this data tells you about Dr. Tsai
Dr. Yong Tsai is a rheumatology in Daytona Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Tsai performed 175,939 Medicare services across 2,277 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tsai received a total of $6,394 from 35 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tsai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 139,600 | $4 | $11 |
| Abatacept infusion (Orencia) | 11,975 | $34 | $87 |
| Denosumab injection (Prolia/Xgeva) | 8,521 | $18 | $41 |
| Infliximab infusion (Remicade) | 7,160 | $26 | $75 |
| Allergy skin test | 1,619 | $3 | $9 |
| Allergy immunotherapy preparation | 1,352 | $11 | $18 |
| Office visit, established patient (30-39 min) | 1,016 | $92 | $150 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 876 | $55 | $100 |
| Test for allergy using allergenic extract injected into skin | 744 | $6 | $10 |
| Office visit, established patient (20-29 min) | 596 | $63 | $90 |
| Allergy injection therapy, multiple injections | 526 | $8 | $23 |
| Administration of chemotherapy into vein, 1 hour or less | 475 | $96 | $202 |
| Injection, methylprednisolone acetate, 40 mg | 353 | $5 | $7 |
| New patient office visit (45-59 min) | 185 | $123 | $225 |
| Administration of chemotherapy into vein, each additional hour | 179 | $21 | $47 |
| Joint injection, major joint | 160 | $43 | $102 |
| Injection of trigger points, 1-2 muscles | 142 | $35 | $75 |
| Chronic care management, first 20 min/month | 95 | $48 | $75 |
| Acupuncture with electrical stimulation, initial 15 minutes | 70 | $31 | $75 |
| Destruction of peripheral nerve or branch | 53 | $124 | $317 |
| Injection into tendon or ligament | 49 | $33 | $75 |
| New patient office visit (30-44 min) | 36 | $65 | $165 |
| Office visit, established patient, complex (40-54 min) | 27 | $143 | $200 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $17 | $50 |
| New patient office visit, complex (60-74 min) | 24 | $162 | $250 |
| Office visit, established patient (10-19 min) | 17 | $38 | $65 |
| Injection, methylprednisolone acetate, 20 mg | 16 | $3 | $5 |
| Aspiration and/or injection of fluid from medium joint | 14 | $38 | $80 |
| Test to measure expiratory airflow and volume | 12 | $21 | $50 |
| Test to determine lung volumes using sensors | 11 | $42 | $75 |
| Test to examine how well the lungs exchange gases | 11 | $44 | $75 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tsai is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tsai experienced with certolizumab injection (cimzia)?
Does Dr. Tsai receive payments from pharmaceutical companies?
How do Dr. Tsai's costs compare to other rheumatologys in Daytona Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology